p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells

Targeting p53 for Novel Anticancer Therapy

(2014) Zhen Wang et al.   Translational Oncology

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

(2012) Cynthia X. Ma et al.   JOURNAL OF CLINICAL INVESTIGATION

Suppression of Glucosylceramide Synthase Restores p53-Dependent Apoptosis in Mutant p53 Cancer Cells

(2011) Y.-Y. Liu et al.   CANCER RESEARCH

Apoptotic cell signaling in cancer progression and therapy

(2011) Jessica Plati et al.   Integrative Biology

Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer

(2011) E P Booy et al.   ONCOGENE

c-Rel Deficiency Increases Caspase-4 Expression and Leads to ER Stress and Necrosis in EBV-Transformed Cells

(2011) Aníbal Valentín-Acevedo et al.   PLoS One

Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing

(2010) Gina B. Scott et al.   BIOCHEMICAL JOURNAL

Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer

(2010) Anupam Bishayee   Frontiers in Bioscience-Landmark

MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression

(2010) Ming Zhou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis

(2009) C. Morel et al.   MOLECULAR AND CELLULAR BIOLOGY

A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer

(2009) Marie-Anne Debily et al.   PLoS One

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

(2008) Monzur Rahman et al.   BREAST CANCER RESEARCH AND TREATMENT